Christopher A. Kroeger, Chief Executive Officer at MapLight Therapeutics, Inc. (MPLT), sold 49,744 shares at $27.50 ($1.4M) on 2026-05-04, disclosed to the SEC on 2026-05-06.
Scheduled sale ($1.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 9,136 | $251K | 17.8% |
| 2 | $28.37 | 5,427 | $154K | 10.9% |
| 3 | $29.56 | 311 | $9K | 0.7% |
| 4 | $30.08 | 697 | $21K | 1.5% |
| 5 | $28.12 | 9,544 | $268K | 19.0% |
| 6 | $29.00 | 928 |
| $27K |
| 1.9% |
| 7 | $28.04 | 8,098 | $227K | 16.1% |
| 8 | $29.13 | 15,603 | $455K | 32.2% |
| Total | $28.39 avg | 49,744 | $1.4M | 100% |
| Filing → |
| MPLT | SELL | 2026-05-11 | $1.9M | — | Filing → |
| MPLT | SELL | 2026-04-17 | $521K | — | Filing → |